- Newsroom
- Here
News
Element Biosciences Raises Over $277 Million to Develop and Commercialize Differentiated Products and Continue Rapid Growth
Element Biosciences Fortifies its Executive Team with Experts in Artificial Intelligence and Product Development
Element Biosciences Announces Record Sequencer Installation Growth Ahead of Participation in Investor Conferences
Element Biosciences Announces Availability of AVITI24, the First Benchtop Sequencer Capable of Direct Cell Profiling